Provided by Tiger Trade Technology Pte. Ltd.

JOINN

24.460
-0.840-3.32%
Volume:4.99M
Turnover:121.31M
Market Cap:18.32B
PE:61.15
High:25.300
Open:24.960
Low:23.820
Close:25.300
52wk High:29.980
52wk Low:15.010
Shares:749.00M
HK Float Shares:119.00M
Volume Ratio:1.28
T/O Rate:4.20%
Dividend:0.14
Dividend Rate:0.57%
EPS(LYR):0.400
ROE:5.94%
ROA:-1.00%
PB:1.84
PE(LYR):61.15
PS:9.32

Loading ...

JOINN Releases 2025 Annual Report; Online Publication and Print Request Details for Non-Registered Shareholders

Bulletin Express
·
Apr 29

JOINN 2025年净利润大幅增长三倍,治理架构与业务布局持续优化

Bulletin Express
·
Apr 29

JOINN Laboratories Q1 2026 Net Profit Jumps 479.67% to RMB238.36 Million, Boosted by Biological Asset Revaluation

Bulletin Express
·
Apr 29

JOINN Reports 479.67% Surge in Q1 Net Profit Attributable to Shareholders

Stock News
·
Apr 29

JOINN Schedules 29 April 2026 Board Meeting for First-Quarter 2026 Results Approval

Bulletin Express
·
Apr 17

CXO Concept Stocks Lead Declines in Hong Kong Market as Overseas Investment Environment Enters Volatile Phase

Stock News
·
Apr 17

Pharmaceutical Innovation Sector Gains Policy Support as State Council Issues Guidelines on Drug Pricing Mechanisms (With Relevant Stocks)

Stock News
·
Apr 15

JOINN Shares Surge Over 4% Intraday as Safety Assessment Sector Sees Volume and Price Growth

Stock News
·
Apr 10

HK Movers | Pharmaceutical Stocks Rally With Joinn up 7%

Tiger Newspress
·
Apr 09

JOINN Reports No Change in Share Capital for March 2026; Confirms Public-Float Compliance

Bulletin Express
·
Apr 08

Robust CXO Earnings Boost Performance: Huabao Fund's HK Connect Medical ETF and Medical ETF Rise Up to 2%

Deep News
·
Mar 31

Stock Track | JOINN Laboratories Soars 14.95% in Morning Trading After Annual Net Profit Triples on Biological Asset Gains

Stock Track
·
Mar 31

HK Movers | Biotech Stocks Jump. JOINN up 12%; Asymchem up 11%; Wuxi Bio up 5%

Tiger Newspress
·
Mar 31

JOINN Laboratories Shares Surge Over 14% in Morning Trading Following Tripling of Annual Net Profit

Stock News
·
Mar 31

JOINN Proposes Comprehensive Charter Revision and Nominates Zhou Fengyuan as Non-Executive Director

Bulletin Express
·
Mar 30

JOINN Declares RMB 0.12 Final Dividend for FY 2025, Payment Slated for 31 Aug 2026

Bulletin Express
·
Mar 30

Major Shareholder's Full Exit Raises Doubts on JOINN's Primate-Based Business Model

Deep News
·
Mar 20

Prominent Suzhou Gu Family to Fully Divest from Joinn Laboratories?

Deep News
·
Mar 17

JOINN Laboratories Plummets in Dual-Listed Shares as Long-Term Shareholder Exits Entire Stake

Deep News
·
Mar 17

Joinn Laboratories Subsidiary Purchases Asset Management Plan from CITIC

MT Newswires Live
·
Mar 17